Medical Affairs Director
Ironwood Pharmaceuticals
Medical Affairs Director
Ironwood Pharmaceuticals
Develops and commercializes GI therapeutics
Ironwood Pharmaceuticals is a leading global gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients. We are pioneers in the development of LINZESS® (linaclotide), the U.S. branded prescription market leader for adults with irritable bowel syndrome with constipation or chronic idiopathic constipation. Ironwood is also advancing apraglutide, a next-generation, long-acting synthetic GLP-2 analog being developed for rare gastrointestinal diseases, including short bowel syndrome with intestinal failure, as well as several earlier stage assets. Building upon our history of GI innovation, we keep patients at the heart of our R&D and commercialization efforts to reduce the burden of GI diseases and address significant unmet needs.
Position Summary:
As Medical Affairs Director, this position will serve as a medical scientific representative to health care professionals and basic science and clinical investigators, building stakeholder relationships through scientific exchange. In this role, you will contribute to Ironwood’s mission by providing development of the medical strategy for assigned assets within medical affairs. Internally the individual in this role serves as a medical scientific expert, expanding Ironwood’s knowledge and capabilities through training, translation and communication of medical scientific evidence and by contributing to R&D and commercial strategies which foster innovation through identification of unmet medical needs.
Key Responsibilities:
Key Performance Indicators:
Ideal Background:
Ironwood Pharmaceuticals is an equal opportunity employer welcoming diversity in our workforce.
Ironwood currently anticipates that the initial base salary for this position could range from between $202,000 to $236,040. The actual base salary will depend, in part, on the successful candidate’s qualifications for the role, including education and experience. Ironwood offers a comprehensive compensation and benefits program to eligible employees, including Restricted Stock Unit awards; eligibility to participate in either a bonus or sales incentive program; company-sponsored 401(k) with matching contributions; eligibility for medical, dental, vision and prescription drug benefits; wellness stipends; and a generous vacation/holiday schedule.
#LI-Hybrid
Develops and commercializes GI therapeutics
Ironwood develops and commercializes medicines for gastrointestinal diseases, with a focus on irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC). Its therapies aim to alleviate GI symptoms and improve GI function through medicines developed via research and development and supported by strategic partnerships. The company differentiates itself through deep GI biology expertise and collaborations that help bring differentiated products to patients in a competitive biopharma market. Its goal is to deliver effective GI medicines that provide value to patients, healthcare providers, and shareholders, enabling ongoing progress in GI disease therapies.
Explore more opportunities at Ironwood Pharmaceuticals